What is ADIL stock price today?

ADIL (Adial Pharmaceuticals Inc) stock is trading at $2.32 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is ADIL stock going up or down today?

ADIL stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy ADIL stock now?

The decision to buy ADIL depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is ADIL a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for ADIL based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is ADIL stock overvalued or undervalued?

Use our DCF valuation calculator to determine if ADIL is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is ADIL's P/E ratio?

P/E ratio data for ADIL will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is ADIL's market cap?

ADIL (Adial Pharmaceuticals Inc) has a market capitalization of $0.01 billion, making it a small-cap stock.

What is ADIL's price to book ratio?

ADIL trades at a price-to-book (P/B) ratio of 1.43, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does ADIL pay dividends?

ADIL does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is ADIL's dividend yield?

ADIL does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is ADIL stock a good long-term investment?

ADIL's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is ADIL's revenue growth rate?

Revenue growth data for ADIL is available on our dashboard with detailed financial statement analysis.

Profitability metrics for ADIL are available on our dashboard with complete income statement analysis.

What are the risks of investing in ADIL?

Key risks for ADIL include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does ADIL compare to its competitors?

Compare ADIL to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize ADIL's performance and positioning.

What is ADIL's stock price target for 2026?

Our AI model provides price targets for ADIL based on fundamental analysis: Bull case $3.02 (+30%), Base case $2.67 (+15%), Bear case $2.09 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about ADIL?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for ADIL. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is ADIL's next earnings report?

ADIL reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

ADIL - Adial Pharmaceuticals Inc

NYSE * Healthcare * Biotechnology

$2.32

$-0.10 (-4.13%)

About Adial Pharmaceuticals Inc

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company's lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders. The company was founded in 2010 and is based in Glen Allen, Virginia.

ADIL Key Statistics

Market Cap

$5.19M

P/B Ratio

1.43

EPS

$-4.89

Employees

How ADIL Compares to Peers

ADIL is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 5

Growth Rank

N/A

of 5

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
ADIL(This stock)	$5.19M	N/A	0%	0.0%	-
AMGNAmgen Inc	$186.52B	24.0	0%	0.2%	vs AMGN
GILDGilead Sciences	$160.15B	17.5	0%	0.3%	vs GILD
VRTXVertex Pharmaceuticals	$112.12B	26.2	0%	0.4%	vs VRTX
REGNRegeneron Pharmaceuticals	$64.89B	15.1	0%	0.3%	vs REGN
BIIBBiogen Inc	$29.00B	21.1	0%	0.1%	vs BIIB

Adial Pharmaceuticals Inc Company Information

Headquarters: 4870 Sadler Road, Glen Allen, VA, United States, 23060, undefined
Website: www.adial.com
Sector: Healthcare
Industry: Biotechnology

Data Updated: June 5, 2026 at 11:04 AM EDT

Ready to invest in ADIL?

Commission-free trading available. Affiliate links.

ADIL Lician Score

5% confidence

4.0/10

Neutral

ADIL has a Lician Score of 4/10 (Average). Areas of concern: Growth.

value

5.0

growth

2.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates ADILacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

ADIL Financial Snowflake

5-axis analysis across key investment dimensions

4.4/10

Neutral

5.0

Value

Valuation vs. sector peers

2.0

Growth

Revenue & earnings trajectory

5.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for ADIL

Dashboard

Enter a ticker to analyze